Cat. #162333
Glioblastoma WHO IV spheroid cell line, NCH1425
Cat. #: 162333
Organism: Human
Tissue: Brain
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Christel Herold-Mende
Institute: Heidelberg University
Primary Citation: Martija et al. 2023. Acta Neuropathol Commun. 11(1):177. PMID: 37936247.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Glioblastoma WHO IV spheroid cell line, NCH1425
- Cancer: Brain
- Organism: Human
- Tissue: Brain
- Growth properties: Mixed - adherent and suspension
- Description: Glioblastoma WHO IV spheroid cell line, NCH1425
- Biosafety level: 2
Handling
- Growth medium: DMEM/F-12 with GlutaMAX (Gibco 31331028), supplemented with B-27 (Gibco 12587010), 20 ng/mL human EGF, 20 ng/mL of human FGF-basic and 1% antibiotic–antimycotic
- Temperature: 37°C
- Atmosphere: 5% CO2
References
- Martija et al. 2023. Acta Neuropathol Commun. 11(1):177. PMID: 37936247.
- Remy et al. 2022. Cancers. 14(2):339. PMID: 35053502.
- Hoja et al. 2016. Oncotarget. 7(39):62989-63002. PMID: 27556305.
